Roundup of Recent Tobacco Product Review Actions

This Week in CTP - Updates from the Center for Tobacco Products FDA continues to review tobacco product marketing applications and issue decisions on those submissions. In July, FDA issued 6 Not Substantially Equivalent (NSE) orders and companies withdrew 22 SE reports from the review process. As of July 31, 2014, 42% of regular SE reports have been resolved with a final decision of refuse-to-accept, withdrawn, substantially equivalent, or NSE.   More information on these actions, and a summary of all the actions FDA has taken, can be found on our Tobacco Product Marketing Orders webpage.   You are subscribed to FDA Tobacco Products Email Updates. Subscriber Services: Manage Preferences | Unsubscribe | Help with this service If you have questions, please email AskCTP@fda.hhs.gov or call 1-877-CTP-1373. Food and Drug Administration | 10903 New Hampshire Avenue  | Silver Spring, MD 20993  | www.fda.gov/tobacco This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420